Biogen, Inc. (BIIB)
195.88
+3.26
(+1.69%)
USD |
NASDAQ |
Jun 09, 11:17
Biogen Research and Development Expense (Quarterly) : 471.10M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.354B |
| AbbVie, Inc. | 2.472B |
| Amgen, Inc. | 1.719B |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Ionis Pharmaceuticals, Inc. | 210.17M |